Ability Biologics partners with Mila - Quebec Artificial Intelligence Institute to advance AI innovations in antibody discovery. Read the full release on https://ability.bio
Ability Biologics
Biotechnology Research
Montreal, Quebec 1,086 followers
Developing innovative targeted immuno therapeutics to addressing unmet medical needs for cancer and autoimmune diseases
About us
Our Mission: Develop innovative, targeted, immune modulating biotherapeutics to address unmet medical needs in patients with cancer and autoimmune diseases. The premier biotherapeutic targeting company Our powerful AbiLeap™ discovery engine combines massively parallel, continuously learning AI with an extensive database of antigen-antibody interactions to generate fully human, IgG-based multispecific antibodies of exquisite selectivity and affinity. The antibodies respond to environmental signals within the cellular microenvironment, generating logic-gated therapeutics. We are dedicated to developing the most potent and selective antibody therapeutics for areas of great unmet need.
- Website
-
https://ability.bio
External link for Ability Biologics
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Montreal, Quebec
- Type
- Privately Held
- Founded
- 2023
- Specialties
- biotherapeutics, AI/ML, and antibodies
Locations
-
Primary
Get directions
3 Place Ville-Marie
Montreal, Quebec H3B 2E3, CA
Employees at Ability Biologics
Updates
-
Ability Biologics today announces the final closing of its #seedfunding, raising a total of US$ 18 million. More about this financing and Ability's vision to generate novel, highly targeted immunomodulators on ability.bio Ability Biologics annonce aujourd'hui la clôture de son financement de démarrage de 18 millions $ US pour la génération de nouveaux immunomodulateurs hautement ciblés. ability.bio
-
SAVE THE DATE: Dr. Jean-Philippe Buerckert VP Technology at Ability Biologics will attend the Gordon Research Conferences on #Antibody Biology & Engineering to be held March 17-22 in Lucca, Italy.
-
-
We're excited to share our new job opportunity with you! If you looking to join a dynamic and growing team focused on delivering tomorrow’s best in class antibody therapeutics in oncology and immunology, click the link below: ___________________ Nous sommes ravis de vous partager une nouvelle opportunité d'emploi au sein de notre équipe! Si vous souhaitez rejoindre une équipe dynamique et en pleine croissance qui se consacre à la mise au point des meilleurs anticorps thérapeutiques de demain dans les domaines de l'oncologie et de l'immunologie, cliquez sur le lien ci-dessous : https://lnkd.in/gtejqFak
-
We're excited to share our new job opportunity with you! If you looking to join a dynamic and growing team focused on delivering tomorrow’s best in class antibody therapeutics in oncology and immunology, click the link below: ___________________ Nous sommes ravis de vous partager une nouvelle opportunité d'emploi au sein de notre équipe! Si vous souhaitez rejoindre une équipe dynamique et en pleine croissance qui se consacre à la mise au point des meilleurs anticorps thérapeutiques de demain dans les domaines de l'oncologie et de l'immunologie, cliquez sur le lien ci-dessous : https://lnkd.in/gmxtKieh
-
Press Release 6 December 2023 Ability Biologics Unveils Discovery Platform that Generates Antibodies with Unparalleled Specificity and Selectivity Company emerges from stealth with the closing of $12 million seed funding https://lnkd.in/e3VjSqTf
Microsoft Word - Ability Seed Round PR English for release 20231206
ability.bio